Longitudinal approaches to Alzheimer’s studies
What contributes towards biomarker expression in Alzheimer’s disease?
Pieter Jelle Visser
Tau fragments as novel disease biomarkers: a pilot study for a plasma protein signature for AD
The future of classifying and diagnosing dementia: a perspective
The role of tau in autosomal dominant Alzheimer’s disease